前往化源商城

European Journal of Drug Metabolism and Pharmacokinetics 1989-01-01

Mephenytoin stereoselective elimination in the rat: II. Comparison of mephenytoin stereoselective clearance during chronic intravenous and hepatic portal vein administration.

S H Akrawi, P J Wedlund

文献索引:Eur. J. Drug Metab. Pharmacokinet. 14(4) , 269-78, (1989)

全文:HTML全文

摘要

The stereoselective clearances of R- and S-mephenytoin were determined in rats receiving either an intravenous or hepatic portal vein infusion of racemic mephenytoin. The mean +/- SD intravenous clearances of R- and S-mephenytoin were 1630 +/- 250 ml/hr and 630 +/- 250 ml/hr, respectively. The corresponding portal vein clearances for these enantiomers were 2560 +/- 1230 ml/hr (R-mephenytoin) and 540 +/- 230 ml/hr (S-mephenytoin). In spite of the slightly higher clearance for R-mephenytoin following portal vein administration, the difference between the intravenous and portal vein clearances for R- or S-mephenytoin were not found to be significant. Subsequent computer simulations of the data indicated there was less than a 5% probability that this result could be attributed solely to interanimal variability in drug clearance. The estimated extraction ratio of R-mephenytoin by the liver was modest and suggested mephenytoin may undergo a substantial degree of extrahepatic elimination in the rat.

相关化合物

结构式 名称/CAS号 全部文献
S-(+)-N-去甲基美芬妥英 结构式 S-(+)-N-去甲基美芬妥英
CAS:65567-34-2
(R)-(-)-苯乙基内酰脲 结构式 (R)-(-)-苯乙基内酰脲
CAS:65567-32-0
5-乙基-5-苯基咪唑烷-2,4-二酮 结构式 5-乙基-5-苯基咪唑烷-2,4-二酮
CAS:631-07-2